1. Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (December 2019) Authors: Cazzaniga, M.E.; Pinotti, G.; Montagna, E.; Amoroso, D.; Berardi, R.; Butera, A.; Cagossi, K.; Cavanna, L.; Ciccarese, M.; Cinieri, S.; Cretella, E.; De Conciliis, E.; Febbraro, A.; Ferraù, F.; Ferzi, A.; Fiorentini, G.; Fontana, A.; Gambaro, A.R.; Garrone, O.; Gebbia, V. Journal: Breast Issue: Volume 48(2019) Page Start: 7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe. (October 2021) Authors: Moscetti, L.; Sperduti, I.; Frassoldati, A.; Musolino, A.; Nasso, C.; Toss, A.; Omarini, C.; Dominici, M.; Piacentini, F. Journal: Breast Issue: Volume 59(2021) Page Start: 232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1849 Italian observational study of Eribulin Mesylate in patients with advanced breast cancer: ESEMPiO study. (September 2015) Authors: Barni, S.; Fontanella, C.; Del Mastro, L.; Livraghi, L.; Morritti, M.; Pizzuti, L.; Michelotti, A.; Lutrino, E.S.; Ciccarese, M.; Musolino, A.; Quercia, S.; Garrone, O.; Pellegrino, A.; Pistelli, M.; Martella, F.; Iezzi, L.; Mentuccia, L.; Latorre, A.; D'Onofrio, L.; Porcu, L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RZISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012. (17th June 2021) Authors: Mattioli, V.; Crocetti, E.; Dal Maso, L.; Buzzoni, C.; Franceschi, S.; Serraino, D.; Vaccarella, S.; Ferretti, S.; Busco, S.; Fedeli, U.; Varvarà, M.; Falcini, F.; Zorzi, M.; Carrozzi, G.; Mazzucco, W.; Gasparotti, C.; Iacovacci, S.; Toffolutti, F.; Cavallo, R.; Stracci, F. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A new predictor–corrector approach for the numerical integration of coupled electromechanical equations. (30th July 2015) Authors: Tripodi, E.; Musolino, A.; Rizzo, R.; Raugi, M. Journal: International journal for numerical methods in engineering Issue: Volume 105:Number 4(2016) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. RISK OF HEMOLYMPHOPOIETIC NEOPLASM BEFORE AND AFTER THYROID CANCER. A POPULATION‐BASED STUDY IN ITALY, 1998‐2012. (17th June 2021) Authors: Mattioli, V.; Crocetti, E.; Dal Maso, L.; Buzzoni, C.; Franceschi, S.; Serraino, D.; Vaccarella, S.; Ferretti, S.; Busco, S.; Fedeli, U.; Varvarà, M.; Falcini, F.; Zorzi, M.; Carrozzi, G.; Mazzucco, W.; Gasparotti, C.; Iacovacci, S.; Toffolutti, F.; Cavallo, R.; Stracci, F. Journal: Hematological oncology Issue: Volume 39(2021)Supplement 2 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer. (October 2022) Authors: Viansone, A.; Pellegrino, B.; Omarini, C.; Pistelli, M.; Boggiani, D.; Sikokis, A.; Uliana, V.; Zanoni, D.; Tommasi, C.; Bortesi, B.; Bonatti, F.; Piacentini, F.; Cortesi, L.; Camisa, R.; Sgargi, P.; Michiara, M.; Musolino, A. Journal: Breast Issue: Volume 65(2022) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A fail-safe magnetorheological clutch excited by permanent magnets for the disengagement of automotive auxiliaries. (November 2014) Authors: Bucchi, F.; Forte, P.; Frendo, F.; Musolino, A.; Rizzo, R. Journal: Journal of intelligent material systems and structures Issue: Volume 25:Number 16(2014:Nov.) Page Start: 2102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study. (January 2018) Authors: Musolino, A.; Falcini, F.; Sikokis, A.; Boggiani, D.; Rimanti, A.; Pellegrino, B.; Silini, E.M.; Campanini, N.; Barbieri, E.; Zamagni, C.; Degli Esposti, R.; Cortesi, L.; Bisagni, G.; Cavanna, L.; Frassoldati, A.; Sgargi, P.; Michiara, M. Journal: European journal of cancer Issue: Volume 88(2018) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study. (October 2017) Authors: Alù, M.; Ancona, C.; Andreis, D.; Bajardi, E.; Benedetto, C.; Berardi, R.; Bordin, E.; Butti, C.; Capri, G.; Cicchiello, F.; Cocciolone, V.; Dester, M.; D'Onofrio, L.; Febbraro, A.; Ferrarini, I.; Fotia, V.; Gervasi, E.; Guaitoli, G.; Licata, L.; Liscia, N. Journal: Breast Issue: Volume 35(2017) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗